alpha(1)-Antitrypsin, an acute-phase reactant in many species, protect
s significantly against the lethality induced by TNF or endotoxin in m
ice. The protection is optimal with a single dose of at least 300 mu g
i.p. or 100 mu g i.v. given 2 h before a lethal challenge, either wit
h a low dose of TNF in the presence of galactosamine or a higher dose
of murine TNF alone. Under optimal conditions, the drop in body temper
ature, the release of liver transaminases, and the increase in clottin
g time are also inhibited, alpha(1)-Antitrypsin does not protect again
st a lethal dose of platelet-activating factor. It is suggested that t
he protection is due to reduced release of platelet-activating factor.